NCT01868802

Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Paul J. Lamothe · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

A randomized multicentric parallel arms study involving the use of ketamine for treatment-resistant depression will be held at three national health provider clinics in the Mexican population. The purpose of this study is to determine whether clinical response seen in previous studies is replicable in this population.

Conditions

• Depressive Disorder,
• Treatment-Resistant Depression

Interventions

Type	Name	Description
DRUG	Ketamine	A single dose of 0.5mg/kg intravenous ketamine infusion will be administered over 40 minutes.
DRUG	Placebo	Saline at 0.9% intravenous infusion will be administered over 40 minutes.

Timeline

• Start date: 2013-09-01
• Primary completion: 2016-05-01
• First posted: 2013-06-05
• Last updated: 2015-03-17

Locations

1 site across 1 country: Mexico